Celgene pursues neuro breakthrough with $150m Prosena deal

19:55 EDT 20 Mar 2018 | pharmaphorum

Celgene is pushing further into the field of neuroscience and dementia research with an alliance with Dublin-based biotech Prosena. Celgene has become a ‘big biotech’ thanks to its stellar growth of its multiple myeloma blockbuster Revlimid, but i...

Original Article: Celgene pursues neuro breakthrough with $150m Prosena deal


More From BioPortfolio on "Celgene pursues neuro breakthrough with $150m Prosena deal"

Quick Search


Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...